Neurocrine Biosciences CEO Kevin Gorman's 2020 pay jumps 47% to $14M
Neurocrine Biosciences reports 2020 executive compensation
By ExecPay News
Published: April 9, 2021
Neurocrine Biosciences reported fiscal year 2020 executive compensation information on April 9, 2021.
In 2020, five executives at Neurocrine Biosciences received on average a compensation package of $8M, a 35% increase compared to previous year.
Average pay of disclosed executives at Neurocrine Biosciences
Kevin C. Gorman, Chief Executive Officer, received $14M in total, which increased by 47% compared to 2019. 51% of Gorman's compensation, or $7.1M, was in option awards. Gorman also received $543K in bonus, $775K in salary, $5.4M in stock awards, as well as $63K in other compensation.
For fiscal year 2020, the median employee pay was $241,848 at Neurocrine Biosciences. Therefore, the ratio of Kevin C. Gorman's pay to the median employee pay was 57 to one.
Kyle W. Gano, Chief Development and Strategy Officer, received a compensation package of $7.2M, which increased by 53% compared to previous year. 52% of the compensation package, or $3.7M, was in option awards.
Eric Benevich, Chief Commercial Officer, earned $6.7M in 2020, a 16% increase compared to previous year.
Matthew C. Abernethy, Chief Financial Officer, received $6.3M in 2020, which increases by 8% compared to 2019.
Eiry W. Roberts, Chief Medical Officer, earned $5.8M in 2020, a 19% increase compared to previous year.
Related executives
Kevin Gorman
Neurocrine Biosciences
Chief Executive Officer
Matthew Abernethy
Neurocrine Biosciences
Chief Financial Officer
Eric Benevich
Neurocrine Biosciences
Chief Commercial Officer
Kyle Gano
Neurocrine Biosciences
Chief Development and Strategy Officer
Eiry Roberts
Neurocrine Biosciences
Chief Medical Officer
You may also like
Source: SEC filing on April 9, 2021.